Risk Factors of Hypersensitivity to Carboplatin in Patients with Gynecologic Malignancies

We evaluated the prevalence of and risk factors for hypersensitivity reactions related to carboplatin, which is commonly used to treat gynecological malignancies. All women with pathologically documented ovarian, fallopian tube, or primary peritoneal cancer treated with carboplatin alone or a carbop...

Descripción completa

Detalles Bibliográficos
Autores principales: Tai, Yu-Hsiao, Tai, Yi-Jou, Hsu, Heng-Cheng, Lee, Shu-Ping, Chen, Yun-Yuan, Chiang, Ying-Cheng, Chen, Yu-Li, Chen, Chi-An, Cheng, Wen-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681487/
https://www.ncbi.nlm.nih.gov/pubmed/29163180
http://dx.doi.org/10.3389/fphar.2017.00800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681487/
https://www.ncbi.nlm.nih.gov/pubmed/29163180
http://dx.doi.org/10.3389/fphar.2017.00800

Ejemplares similares